Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × OTHER_GOV × Hepatitis C × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Vomiting 1 Skin Cancer Face 1 Recurrence 1 Pathologic Complete Response 1 Parasomnias 1 Pain, Intractable 1 Ovarian Neoplasms 1 Opportunistic Infections 1 Neoplasm Metastasis 1 Nausea 1 Melanoma 1 Medulloblastoma 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Inflammation 1 Hepatitis C, Chronic 1 Hepatitis C 1 Hematologic Neoplasms 1 Glioblastoma 1 Fatigue 1 Epstein-Barr Virus Infections 1 Dupuytren Contracture 1 Dizziness 1 Cytomegalovirus Infections 1 Contracture 1

Interventions

elbasvir-grazoprevir drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04546802 2020-09-14

HATCHeT

Bayside Health

Phase 3 Withdrawn

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡